Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

CBL-514 is the first product to treat cellulite at the raised areas. Currently, there is no effective and safe cellulite treatment on the market. The global...

Related Keywords

United States ,Taiwan ,American ,Fibrosclerotic Panniculopathy ,Bax Bcl ,American Society Of Plastic Surgeons ,Hexsel Cellulite Severity Scale ,Local Fat Reduction ,Fast Track Designation ,Orphan Drug Designation ,Track Designation ,Significant Reductions ,Cellulite Severity Across Three Dosage ,Edematous Fibrosclerotic Panniculopathy ,Participants Demonstrated ,Ozone Level ,Improvement Among ,About Cellulite ,American Society ,Plastic Surgeons ,Caliway Biopharmaceuticals ,